Current Osteoporosis Reports ( IF 4.2 ) Pub Date : 2024-01-18 , DOI: 10.1007/s11914-023-00843-1 Alexander Harris 1 , Amy Creecy 1 , Olatundun D Awosanya 1 , Thomas McCune 2, 3 , Marie V Ozanne 4 , Angela J Toepp 2, 5 , Melissa A Kacena 1, 6 , Xian Qiao 2, 7, 8
Purpose of Review
SARS-CoV-2 infection, the culprit of the COVID-19 pandemic, has been associated with significant long-term effects on various organ systems, including bone health. This review explores the current understanding of the impacts of SARS-CoV-2 infection on bone health and its potential long-term consequences.
Recent Findings
As part of the post-acute sequelae of SARS-CoV-2 infection, bone health changes are affected by COVID-19 both directly and indirectly, with multiple potential mechanisms and risk factors involved. In vitro and preclinical studies suggest that SARS-CoV-2 may directly infect bone marrow cells, leading to alterations in bone structure and osteoclast numbers. The virus can also trigger a robust inflammatory response, often referred to as a "cytokine storm", which can stimulate osteoclast activity and contribute to bone loss. Clinical evidence suggests that SARS-CoV-2 may lead to hypocalcemia, altered bone turnover markers, and a high prevalence of vertebral fractures. Furthermore, disease severity has been correlated with a decrease in bone mineral density. Indirect effects of SARS-CoV-2 on bone health, mediated through muscle weakness, mechanical unloading, nutritional deficiencies, and corticosteroid use, also contribute to the long-term consequences. The interplay of concurrent conditions such as diabetes, obesity, and kidney dysfunction with SARS-CoV-2 infection further complicates the disease's impact on bone health.
Summary
SARS-CoV-2 infection directly and indirectly affects bone health, leading to potential long-term consequences. This review article is part of a series of multiple manuscripts designed to determine the utility of using artificial intelligence for writing scientific reviews.
中文翻译:
SARS-CoV-2 及其对骨骼健康的多方面影响:机制和临床证据
审查目的
SARS-CoV-2 感染是 COVID-19 大流行的罪魁祸首,与对各种器官系统(包括骨骼健康)的重大长期影响有关。本综述探讨了目前对 SARS-CoV-2 感染对骨骼健康影响及其潜在长期后果的理解。
最新发现
作为 SARS-CoV-2 感染急性后遗症的一部分,骨骼健康变化受到 COVID-19 的直接和间接影响,涉及多种潜在机制和风险因素。体外和临床前研究表明,SARS-CoV-2 可能直接感染骨髓细胞,导致骨骼结构和破骨细胞数量发生变化。该病毒还可以引发强烈的炎症反应,通常被称为“细胞因子风暴”,它可以刺激破骨细胞活性并导致骨质流失。临床证据表明,SARS-CoV-2 可能导致低钙血症、骨转换标志物改变和椎骨骨折的高患病率。此外,疾病严重程度与骨密度降低相关。SARS-CoV-2 对骨骼健康的间接影响,通过肌肉无力、机械卸载、营养缺乏和皮质类固醇使用介导,也会导致长期后果。糖尿病、肥胖和肾功能障碍等并发病症与 SARS-CoV-2 感染的相互作用使疾病对骨骼健康的影响进一步复杂化。
总结
SARS-CoV-2 感染直接或间接影响骨骼健康,导致潜在的长期后果。这篇评论文章是一系列多篇手稿的一部分,旨在确定使用人工智能撰写科学评论的效用。